Event Calendar

Life Science Innovation Northwest Conference 2010
(not a CFA Seattle sponsored event)

  This event is closed for registration
Date: 3/16/10
Member Cost: $0.00
Nonmember Cost: $0.00
No cost to investors if qualified at link.
Location: Bell Harbor International Conference Center
Seattle, Washington
Address:

Event Description:
The Washington Biotechnology & Biomedical Association (WBBA) and Burrill & Company are proud to present the region's 10th annual Life Science Innovation Northwestconference in Seattle. Innovation has supercharged the Pacific Northwest's biotech and medical device industries for decades. Our life sciences companies, non-profit research institutes and global health organizations are leading the way. And, we are pushing forward some of the most compelling technology breakthroughs of our time. As such, this year's forum, formerly Invest Northwest,has been refocused and rebranded to better identify and highlight these unique and powerful assets, defining the Pacific Northwest's life sciences sector.

Life Science Innovation Northwestwill bring public and private life sciences companies, research institutions, scientists, entrepreneurs, and our global health community together to discuss and feature some of the most compelling technology breakthroughs of our time,said Chris Rivera, President, WBBA.

Other Information:
Featured Program Highlights:

  • State-of-the-Industry Report by keynote speaker Steven Burrill, Burrill & Company

  • More than 50 companies presenting companies: Some of the most innovative organizations, premier research institutions, long-time experts in immunology, oncology and other chronic diseases, pre-emerging and emerging technologies reveal their latest biotech innovations, medical device and diagnostic technologies, global health initiatives, and bio-fuel and bio-agriculture breakthroughs.

  • Opportunities to explore financial and strategic investments with China delegation. Travis Sullivan, Director Policy and Strategic Planning for the U.S. Department of Commerce will discuss how the United States and the Pacific Northwest partners with China's Innovation industries, views green businesses and jobs, as well as the Department of Commerce's Trade and Promotion.

  • Strategic and Investment Panels Sessions including:

    o From IP to IPO: Several of the Northwest's public life science CEO's (Seattle Genetics, Dendreon, ZymoGenetics, OncoGeniX and Omeros) discuss the pathway to taking a company public.
    o Public/Private Partnerships, why are industry and global health teaming up? Global health leaders and industry executives will discuss why industry and the global health community are partnering to fight some of our most challenging global health care issues?
    o The VC Model at a Crossroads: Where next? A panel of the nation's leading Venture Capitalists will discuss the future of life science capitalization, moderated by Mark Heesen, President, National Venture Capital Association.
    o Investment or Partnership? What is the best direction for your company? Panelists from leading companies, strategic venture partners, and CEO's from some Northwest companies that have recently partnered with larger companies will discuss the best strategic option in today's economy.

  • Emerging Company Speed-Dating: Pre-emerging or emerging companies will pitch their ideas and business plans to leading investors.

  • Poster Sessions: Scientific poster sessions are a fantastic opportunity for pre-emerging companies to share cutting edge innovation with the who's who of life sciences.

    •